MST1 and metabolic dysfunction-associated steatotic liver disease: Notably, several studies have previously shown the inhibitory effect of Mst1 on mitophagy in various disease models, such as cardiac ischemia‒reperfusion models and nonalcoholic fatty liver disease (NAFLD) models56–58.